Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38.
PubMed PubMed Central Article Google Scholar
Caligiuri ME, Perrotta P, Augimeri A, Rocca F, Quattrone A, Cherubini A. Automatic detection of white matter hyperintensities in healthy aging and pathology using magnetic resollauce knagmg: a review. Neuromformatics. 2015;13:261–76.
Kloppenborg RP, Nederkoorn PJ, Geerlings MI, van den Berg E. Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology. 2014;82:2127–38.
Hainsworth AH, Minett T, Andoh J, Forster G, Bhide I, Barrick TR, et al. Neuropathology of white matter lesions, blood-brain barrier dysfunction, and dementia. Stroke. 2017;48:2799–804.
PubMed PubMed Central Article Google Scholar
Coutu JP, Goldblatt A, Rosas HD, Salat DH. Alzheimer’s Disease Neuroimaging Initiative (ADNI). White matter changes are associated with ventricular expansion in aging, mild cognitive impairment, and Alzheimer’S disease. J Alzheimers Dis. 2016;49:329–42.
PubMed PubMed Central Article Google Scholar
Wang L, Leonards CO, Sterzer P, Ebinger M. White matter lesions and depression: a systematic review and meta-analysis. J Psychiatr Res. 2014;56:56–64.
Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr. Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821–5.
Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.
Wolfson L, Wakefield DB, Moscufo N, Kaplan RF, Hall CB, Schmidt JA, et al. Rapid buildup of brain white matter hyperintensities over 4 years linked toambulatory blood pressure, mobility, cognition, and depression in old persons. J Gerontol A Biol Sci Med Sci. 2013;68:1387–94.
PubMed PubMed Central Article Google Scholar
Guevarra AC, Ng SC, Saffari SE, Wong BYX, Chander RJ, Ng KP, et al. Age moderates associations of hypertension, white matter hyperintensities, and cognition. J Alzheimers Dis. 2020;75:1351–60.
Habes M, Erus G, Toledo JB, Zhang T, Bryan N, Launer LJ, et al. White matterhyperintensities and imaging patterns of brain ageing in the general population. Brain. 2016;139:1164–79.
PubMed PubMed Central Article Google Scholar
Abraham HM, Wolfson L, Moscufo N, Guttmann CR, Kaplan RF, White WB. Cardiovascular risk factors and small vessel disease of the brain: blood pressure, white matter lesions, and functional decline in older persons. J Cereb Blood Flow Metab. 2016;36:132–42.
PubMed PubMed Central Article Google Scholar
Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, et al. Midlife hypertention and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol. 2014;21287:1–10.
Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation. 2011;123:266–73.
Wang DQ, Wang L, Wei MM, Xia XS, Tian XL, Cui XH, et al. Relationship between type 2 diabetes and white matter hyperintensity: a systematic review. Front Endocrinol. 2020;11:595962.
Rist PM, Buring JE, Rexrode KM, Cook NR, Rost NS. Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients. Eur J Epidemiol. 2019;34:957–65.
PubMed PubMed Central Article Google Scholar
Andreescu C, Tudorascu D, Sheu LK, Rangarajan A, Butters MA, Walker S, et al. Brain structural changes in late-life generalized anxiety disorder. Psychiatry Res Neuroimaging. 2017;268:15–21.
Karcher HS, Holzwarth R, Mueller HP, Ludolph AC, Huber R, Kassubek J, et al. Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study. Cerebrovasc Dis. 2013;35:341–8.
Smith AD, Refsum H. Homocysteine, B vitamins, and cognitive impairment. Annu Rev Nutr. 2016;36:211–39.
CAS PubMed Article Google Scholar
Tinelli C, Di Pino A, Ficulle E, Marcelli S, Feligioni M. Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Front Nutr. 2019;6:49.
PubMed PubMed Central Article CAS Google Scholar
Cao L, Guo Y, Zhu Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms. Int J Neurosci. 2021;131:362–9.
CAS PubMed Article Google Scholar
Wang CY, Chen ZW, Zhang T, Liu J, Chen SH, Liu SY, et al. Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertension patients. Eur J Intern Med. 2014;25:538–44.
CAS PubMed Article Google Scholar
Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Viswanathan A, et al. Vascular disease and risk factors are associated with cognitive decline in the Alzheimer disease spectrum. Alzheimer Dis Assoc Disord. 2019;29:18–25.
Nelson ME, Andel R, Nedelska Z, Martinkova J, Cechova K, Markova H, et al. The association between homocysteine and memory in older adults. J Alzheimer Dis. 2021;81:413–26.
Smith AD, Refsum H, Bottiglieri T, Fenech M, Hooshmand B, McCaddon A, et al. Homocysteine and dementia: an international consensus statement. J Alzheimers Dis. 2018;62:561–70.
PubMed PubMed Central Article Google Scholar
Tu W, Yan F, Chao B, Ji X, Wang L. Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program, 2018. Front Med. 2021;15:903–12.
Zhao W, Gao F, Lv L, Chen X. The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States. J Hypertens. 2022;40:254–63.
Shokouhi M, Qiu D, Samman Tahhan A, Quyyumi AA, Hajjar I. Differential Associations of diastolic and systolic pressures with cerebral measures in older individuals with mild cognitive impairment. Am J Hypertens. 2018;31:1268–77.
PubMed PubMed Central Article Google Scholar
Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, et al. Midlife hypertention and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol. 2014;21287:1–10.
Li M, Fu B, Dong W. Correlations between plasma homocysteine and MTHFR gene polymorphism and white matter lesions. Folia Neuropathol. 2018;56:301–7.
Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354:407–13. 31
CAS PubMed Article Google Scholar
Katsiki N, Perez-Martinez P, Mikhailidis DP. Homocysteine and non-cardiac vascular disease. Curr Pharm Des. 2017;23:3224–32.
Khan U, Crossley C, Kalra L, Rudd A, Wolfe CD, Collinson P, et al. Homocysteine and its relationship to stroke subtypes in a UK black population: the South London Ethnicity and Stroke Study. Stroke. 2008;39:2943–9.
CAS PubMed Article Google Scholar
Linnebank M, Moskau S, Jürgens A, Simon M, Semmler A, Orlopp K, et al. Association of genetic variants of methionine metabolism with methotrexate‐induced CNS white matter changes in patients with primary CNS lymphoma. Neuro Oncol. 2009;11:2–8.
CAS PubMed PubMed Central Article Google Scholar
Hong ED, Taylor WD, McQuoid DR, Potter GG, Payne ME, Ashley‐Koch A, et al. Influence of the MTHFR C677T polymorphism on magnetic resonance imaging hyperintensity volume and cognition in geriatric depression. Am J Geriatr Psychiatry. 2009;17:847–55.
PubMed PubMed Central Article Google Scholar
Cuadrado-Godia E, Dwivedi P, Sharma S, Ois Santiago A, Roquer Gonzalez J, Balcells M, et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies. J Stroke. 2018;20:302–20.
PubMed PubMed Central Article Google Scholar
Moretti R, Caruso P. The controversial role of homocysteine in neurology: from labs to clinical practice. Int J Mol Sci. 2019;20:231.
PubMed Central Article CAS Google Scholar
Cao L, Guo Y, Zhu Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms. Int J Neurosci. 2021;131:362–9.
CAS PubMed Article Google Scholar
Pang X, Liu J, Zhao J, Mao J, Zhang X, Feng L, et al. Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-KB signal pathway in rat vascular smooth muscle cells. Atherosclerosis. 2014;236:73–81.
CAS PubMed Article Google Scholar
Ma Y, Zhao X, Zhang W, Liu L, Wang Y, Fang R, et al. Homocysteine and ischemic stroke subtype: a relationship study in Chinese patients. Neurol Res. 2010;32:636–41.
CAS PubMed Article Google Scholar
Feng C, Bai X, Xu Y, Hua T, Huang J, Liu XY. Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease. Int J Med Sci. 2013;10:408–12.
留言 (0)